Anti-infective AgentsVFEND (voriconazole) Tablets & Injection
Manufacturer: Pfizer, Inc.
Drug Approval Classification: Original New Drug Application (Approval Date: 11/14/03)
New Indication: This new drug application provides for the use of VFEND (voriconazole) tablets and intravenous injection for esophageal candidiasis.
Medscape Pharmacists. 2003;5(1) © 2003 Medscape
Cite this: December 2003 - Medscape - Dec 15, 2003.